FDA Suspends Review for Non-COVID-19 In Vitro Diagnostics (IVD) Submissions and Expects Review Delays in Non-IVD Products

Publication Date20 April 2021
SubjectLife Sciences,Medical Device User Fee Program (MDUFA IV),Emergency Use Authorization (EUA),FDA,CDRH,Medical Devices,Pharmaceutical Industry
Law FirmWomble Bond Dickinson

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT